Pheiron provides a scalable, secure, and interoperable platform for deep data-driven health management. The company focuses on improving the probability of success in drug development by leveraging causal insights on targets and populations. Pheiron uses AI to map multimodal data to diseases, aiming to enhance the understanding of diseases and inform decision-making in drug development. The platform also supports large-scale exome sequence analysis to identify sex- and age-specific factors in health management.